Live Updates: COVID-19 Cases
  • World 30,965,963
    World
    Confirmed: 30,965,963
    Active: 7,441,222
    Recovered: 22,564,085
    Death: 960,656
  • USA 6,961,357
    USA
    Confirmed: 6,961,357
    Active: 2,542,876
    Recovered: 4,214,779
    Death: 203,702
  • India 5,398,230
    India
    Confirmed: 5,398,230
    Active: 1,011,732
    Recovered: 4,299,724
    Death: 86,774
  • Brazil 4,528,240
    Brazil
    Confirmed: 4,528,240
    Active: 571,613
    Recovered: 3,820,095
    Death: 136,532
  • Russia 1,097,251
    Russia
    Confirmed: 1,097,251
    Active: 171,450
    Recovered: 906,462
    Death: 19,339
  • Peru 762,865
    Peru
    Confirmed: 762,865
    Active: 123,659
    Recovered: 607,837
    Death: 31,369
  • Mexico 688,954
    Mexico
    Confirmed: 688,954
    Active: 123,959
    Recovered: 492,192
    Death: 72,803
  • South Africa 659,656
    South Africa
    Confirmed: 659,656
    Active: 54,282
    Recovered: 589,434
    Death: 15,940
  • Spain 659,334
    Spain
    Confirmed: 659,334
    Active: 628,839
    Recovered: ?
    Death: 30,495
  • Chile 444,674
    Chile
    Confirmed: 444,674
    Active: 14,319
    Recovered: 418,101
    Death: 12,254
  • France 442,194
    France
    Confirmed: 442,194
    Active: 319,346
    Recovered: 91,574
    Death: 31,274
  • Iran 419,043
    Iran
    Confirmed: 419,043
    Active: 37,293
    Recovered: 357,632
    Death: 24,118
  • UK 390,358
    UK
    Confirmed: 390,358
    Active: 348,599
    Recovered: ?
    Death: 41,759
  • Bangladesh 347,372
    Bangladesh
    Confirmed: 347,372
    Active: 88,073
    Recovered: 254,386
    Death: 4,913
  • Saudi Arabia 329,271
    Saudi Arabia
    Confirmed: 329,271
    Active: 15,383
    Recovered: 309,430
    Death: 4,458
  • Pakistan 305,031
    Pakistan
    Confirmed: 305,031
    Active: 6,572
    Recovered: 292,044
    Death: 6,415
  • Turkey 301,348
    Turkey
    Confirmed: 301,348
    Active: 27,786
    Recovered: 266,117
    Death: 7,445
  • Italy 296,569
    Italy
    Confirmed: 296,569
    Active: 43,161
    Recovered: 217,716
    Death: 35,692
  • Germany 272,080
    Germany
    Confirmed: 272,080
    Active: 19,614
    Recovered: 243,000
    Death: 9,466
  • Canada 142,774
    Canada
    Confirmed: 142,774
    Active: 9,376
    Recovered: 124,187
    Death: 9,211
  • Netherlands 91,934
    Netherlands
    Confirmed: 91,934
    Active: 85,659
    Recovered: ?
    Death: 6,275
  • China 85,269
    China
    Confirmed: 85,269
    Active: 171
    Recovered: 80,464
    Death: 4,634
  • Australia 26,885
    Australia
    Confirmed: 26,885
    Active: 2,079
    Recovered: 23,962
    Death: 844
  • S. Korea 22,893
    S. Korea
    Confirmed: 22,893
    Active: 2,545
    Recovered: 19,970
    Death: 378
  • New Zealand 1,811
    New Zealand
    Confirmed: 1,811
    Active: 67
    Recovered: 1,719
    Death: 25

Indian-origin scientist identifies four possible drugs to treat COVID-19

Author at TechGenyz Health
drugs treating covid 19

An Indian-origin researcher in the US and his team have identified four antiviral drugs, including remdesivir that was originally developed in treating Ebola, which may be effective in inhibiting the replication of the novel coronavirus that causes COVID-19.

Kamlendra Singh, an associate professor at the University of Missouri in the US, and his colleagues used computer-aided drug design to examine the effectiveness of remdesivir, 5-fluorouracil, ribavirin, and favipiravir drug in treating COVID-19.

The study, published in the journal Pathogens, found that all four drugs were effective in inhibiting or blocking, the coronavirus’ RNA proteins from making genomic copies of the novel coronavirus.

“As researchers, we have an obligation to search for possible treatments given that so many people are dying from this virus,” Singh said.

“These antiviral drugs, if they turn out to be effective, all have some limitations. But in the midst of a global pandemic, they are worth taking a deeper look at because based on our research, we have reason to believe that all of these drugs could potentially be effective in treating COVID-19,” he said.

The researchers noted that SARS-CoV-2 that causes COVID-19, like all viruses, can mutate and develop resistance to antiviral drugs.

Further testing in a laboratory setting and in patients is needed to better evaluate how the proposed treatments interact with the virus’ RNA polymerase, they said.

“Our goal is to help doctors by providing options for possible treatments of COVID-19, and to ultimately contribute in improving the health outcomes of patients suffering from the infectious disease,” Singh said.

“As researchers, we are simply playing our part in the fight against the pandemic,” he said.

Career

Subscribe